We found that CAP1+ CTCs and CAP1+ leukocyte subpopulations were prevalent in these HNSCC patient samples, while the prevalence rates of CFL1+ and PFN1+ CTCs were relatively low. This evidence concerns the gene CAP1 and head and neck squamous cell carcinoma.